- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alpha Cognition Inc (ACOG)
Alpha Cognition Inc stock price live, this page displays NASDAQ ACOG stock exchange data. View the ACOG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alpha Cognition Inc real time stock price chart below.
What Is the Alpha Cognition Inc Stock Price Today?
The Alpha Cognition Inc stock price today is 8,300.
What Is the Stock Symbol for Alpha Cognition Inc?
The stock symbol for Alpha Cognition Inc is "ACOG."
What Stock Exchange Does Alpha Cognition Inc Trade On?
Alpha Cognition Inc is listed and trades on the NASDAQ stock exchange.
Is Alpha Cognition Inc a Good Stock to Buy?
Determining whether Alpha Cognition Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACOG quote. (ISIN: CA02074J5017)
What Is the Alpha Cognition Inc Stock Price Today?
The Alpha Cognition Inc stock price today is 8,300.
What Is the Stock Symbol for Alpha Cognition Inc?
The stock symbol for Alpha Cognition Inc is "ACOG."
What Stock Exchange Does Alpha Cognition Inc Trade On?
Alpha Cognition Inc is listed and trades on the NASDAQ stock exchange.
Is Alpha Cognition Inc a Good Stock to Buy?
Determining whether Alpha Cognition Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACOG quote. (ISIN: CA02074J5017)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.170
8.600
52 wk Range
4.500
10.140
ACOG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.1708.600
52 wk Range
4.50010.140
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACOG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
18.000
Upside
+116.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Form 8K Alpha Cognition Inc. For: 12 November- Investing.com
- Form 8K Alpha Cognition Inc. For: 12 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.000
(+116.87% Upside)
Alpha Cognition Inc Earnings Call Summary for Q3/2026
- Q3 revenue hit $7.8M, up 30% sequentially and 230% YoY, with prescriptions rising 40% to 11,000 while maintaining 94% gross margin.
- Operating expenses held nearly flat at $13.7M despite revenue growth, narrowing net loss to $7.6M from $8.2M; cash stood at $37.8M.
- Company reaffirmed 2026 operating expense guidance of $50M-$54M and remains on track for operating profitability in 2027.
- Prescriber base exceeded full-year target at 2,438 writers with 50%+ conversion rate, up from 35% in Q2; 80% of facilities reordered.
- No formulary wins expected through 2026; sublingual formulation study inconclusive, prompting new trial in early 2027.
Last Updated: 2026/11/12, 00:26
Read Full TranscriptEarnings
Latest Release
Nov 11, 2026
EPS / Forecast
-0,35 / -0,60
Revenue / Forecast
7,78M / --
Compare ACOG to Peers and Sector
Metrics to compare | ACOG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACOGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.4x | −1.5x | −0.2x | |
PEG Ratio | −0.26 | −0.07 | 0.00 | |
Price/Book | 3.7x | 1.4x | 2.6x | |
Price / LTM Sales | 8.9x | 1.8x | 2.8x | |
Upside (Analyst Target) | 116.9% | 765.4% | 65.0% | |
Fair Value Upside | Unlock | 42.5% | 9.6% | Unlock |
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer’s disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Alpha Cognition (ACOG) Stock Price Today?
The Alpha Cognition stock price today is 8,300 USD.
What Stock Exchange Does Alpha Cognition Trade On?
Alpha Cognition is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Alpha Cognition?
The stock symbol for Alpha Cognition is "ACOG."
What Is the Alpha Cognition Market Cap?
As of today, Alpha Cognition market cap is 186,420M USD.
What Is Alpha Cognition's Earnings Per Share (TTM)?
The Alpha Cognition EPS (TTM) is -1,28.
From a Technical Analysis Perspective, Is ACOG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Alpha Cognition Stock Split?
Alpha Cognition has split 1 times.
What is the current trading status of Alpha Cognition (ACOG)?
As of Nov 14, 2026, Alpha Cognition (ACOG) is trading at a price of 8,300 USD, with a previous close of 8,560 USD. The stock has fluctuated within a day range of 8,170 USD to 8,600 USD, while its 52-week range spans from 4,500 USD to 10,140 USD.
What Is Alpha Cognition (ACOG) Price Target According to Analysts?
The average 12-month price target for Alpha Cognition is 18,000 USD, with a high estimate of 21 USD and a low estimate of 12 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +116,87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.